Yahoo
NYSE - Delayed Quote USD

National Health Investors, Inc. (NHI)

67.04 +0.09 (+0.13%)
At close: 4:00:02 PM EDT
67.04 0.00 (0.00%)
After hours: 4:01:09 PM EDT
Trade NHI on Coinbase
Chart Range Bar
Loading chart for NHI
  • Previous Close 66.95
  • Open 67.57
  • Bid 66.96 x 50000
  • Ask 67.10 x 10000
  • Day's Range 66.94 - 67.80
  • 52 Week Range 63.51 - 91.38
  • Volume 269,392
  • Avg. Volume 340,500
  • Market Cap (intraday) 3.292B
  • Beta (5Y Monthly) 0.52
  • PE Ratio (TTM) 19.38
  • EPS (TTM) 3.46
  • Earnings Date Nov 9, 2026
  • Forward Dividend & Yield 3.76 (5.62%)
  • 1y Target Est 78.50
  • Motley Fool Rating Bullish

National Health Investors, Inc. is a self-managed real estate investment trust (REIT). The Company owns, leases, operates and finances the development of high-quality real estate properties in the United States, focusing on senior housing communities and medical facilities. The Company operates through two reportable segments, Real Estate Investments and SHOP. The Company's real estate property investments include independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities and hospitals. National Health Investors, Inc. was established on October 15th, 1991, and was incorporated in 1991 in Maryland and is based in Murfreesboro, Tennessee.

www.nhireit.com

32

Full Time Employees

December 31

Fiscal Year Ends

Real Estate

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NHI
8.88%
S&P 500 (^GSPC)
10.73%

1-Year Return

NHI
6.41%
S&P 500 (^GSPC)
11.11%

3-Year Return

NHI
57.60%
S&P 500 (^GSPC)
81.91%

5-Year Return

NHI
65.80%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 121.32M
Earnings 55.58M
Profit Margin 45.81%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
20M
40M
60M
80M
100M
120M
36.0%
38.0%
40.0%
42.0%
44.0%

Analyst Insights

View More

Analyst Price Targets

65.00
78.50 Average
67.04 Current
90.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/19/2026
Analyst Wells Fargo
Rating Action Maintains
Rating Equal-Weight
Price Action Lowers
Price Target 78 -> 68

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    38.28%

  • Return on Assets (ttm)

    4.39%

  • Return on Equity (ttm)

    10.72%

  • Revenue (ttm)

    435.78M

  • Net Income Avi to Common (ttm)

    166.52M

  • Diluted EPS (ttm)

    3.46

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    30.39M

  • Total Debt/Equity (mrq)

    80.43%

  • Levered Free Cash Flow (ttm)

    171.98M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: